DOSSIER · 13F-HR · Q1 2026

Royalty Pharma Sub-Manager, LLC

$173M in tracked AUM across 4 positions as of Q1 2026.

RP
CIK 0002081668 · last filed Mar 31, 2026
Total AUM
$173M
as of Q1 2026
Holdings
4
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Royalty Pharma Sub-Manager, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
CYTK
CYTOKINETICS, INC
$65M980K37.4%
02
BCAX
ZENAS BIOPHARMA, INC.
$47M2.4M27.0%
03
BCRX
BIOCRYST PHARMACEUTICALS INC
$37M3.8M21.2%
04
G1110E107
BIOHAVEN LTD
$25M2.9M14.4%

Filing history

2026Q1Mar 31
$173M 0.8%
4 positionsView →
2025Q4Dec 31
$171M
4 positionsView →